Proposed issue of securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Thursday

Announcement Summary

ALTERITY THERAPEUTICS LIMITED

Date of this announcement

Thursday March 26, 2020

The Proposed issue is:

A placement or other

Total number of +securities proposed to be issued

for a placement or other type of issue

Proposed +issue date

Friday March 27, 2020

Refer to next page for full details of the announcement

Part 1 - Entity and announcement details

ALTERITY THERAPEUTICS LIMITED

We (the entity named above) give ASX the following

information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on

a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

of this announcement

Thursday March 26, 2020

placement or other type of issue

Part 7 - Details of proposed placement or other issue

Part 7A - Conditions

7A.1 - Are any of the following approvals required

for the placement or other type of issue?

of court order with +ASIC

approval/condition external to the entity

Part 7B - Issue details

Details of +securities proposed

ASX +Security Code and Description

ATH : ORDINARY FULLY PAID

Maximum Number of +securities proposed to be

Purpose of the issue

and to progress research activities

Offer price details for retail security holders

Will these +securities rank equally in all respects

from their issue date with the existing issued +securities in that class?

Oversubscription & Scale back details

May a scale back be applied to this event?

7C.1 Proposed +issue date

Friday March 27, 2020

7D.1 Has the entity obtained, or is it obtaining,

+security holder approval for the issue under listing rule 7.1?

7D.1b Are any of the +securities proposed to

be issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1?

7D.1b ( i ) How many +securities are proposed

to be issued without security holder approval using the entity's 15% placement capacity under listing rule 7.1?

7D.1c Are any of the +securities proposed to

be issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)?

7D.2 Is a party referred to in listing rule

10.11.1 participating in the proposed issue?

7D.3 Will any of the +securities to be issued

be +restricted securities for the purposes of the listing rules?

7D.4 Will any of the +securities to be issued

be subject to +voluntary escrow?

Part 7E - Fees and expenses

7E.1 Will there be a lead manager or broker

to the proposed issue?

7E.2 Is the proposed issue to be underwritten?

7E.4 Details of any other material fees or costs to be incurred

by the entity in connection with the proposed issue

7F.1 Will the entity be changing its dividend/distribution

policy if the proposed issue proceeds?

7F.2 Any other information the entity wishes

to provide about the proposed issue